Pharmaceutical companies are faced with weightier challenges than testing their applications pre-deployment. They must deal with time-to-market pressures for the advancement and delivery of medical solutions, while also adhering to tight government regulations.  These companies use Shunra to test application modules before rollout to uncover potential areas of performance risk so they can be mitigated proactively prior to deployment, delivering confidence in performance and significant cost savings.